A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT06588855 · RECRUITING
Trial details
- NCT number
- NCT06588855
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-11
- Primary completion
- 2027-01-30
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.